Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'amifostine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 188 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Doolittle, ND; Muldoon, LL; Brummett, RE; Tyson, RM; Lacy, C; Bubalo, JS; Kraemer, DF; Heinrich, MC; Henry, JA; Neuwelt, EA
      Delayed sodium thiosulfate as an otoprotectant against carboplatin-inducedhearing loss in patients with malignant brain tumors

      CLINICAL CANCER RESEARCH
    2. Michieli, M; Michelutti, A; Damiani, D; Ermacora, A; Masolini, P; Stocchi, R; Russo, D
      Amifostine does not inhibit the toxic effects of Anthracycline derivates or Mitoxantrone on MDR tumor cell lines

      LEUKEMIA & LYMPHOMA
    3. Kuittinen, O; Ruokolainen, H; Turpeenniemi-Hujanen, T
      Amifostine does not protect malignant lymphoma cell lines from the cytotoxic effects of various chemotherapeutics in vitro

      LEUKEMIA & LYMPHOMA
    4. Preisler, HD; Venugopal, P; Gregory, SA; Adler, S; Gezer, S; Hsu, WT; Manson, S; Larson, A; Jajeh, A; Slvinick, D; Galvez, A
      High remission rate in acute myeloblastic leukemia with only two days of chemotherapy

      LEUKEMIA & LYMPHOMA
    5. Tao, M; Li, BR; Nayini, J; Sivaraman, S; Song, SW; Larson, A; Toofanfard, M; Chen, H; Venugopal, P; Preisler, HD
      In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    6. Neumeister, P; Jaeger, G; Eibl, M; Sormann, S; Zinke, W; Linkesch, W
      Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome

      LEUKEMIA & LYMPHOMA
    7. Genvresse, I; Lange, C; Schanz, J; Schweigert, M; Harder, H; Possinger, K; Spath-Schwalbe, E
      Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study

      ANTI-CANCER DRUGS
    8. Lin, HS; Lin, TS; Lai, RS; D'Rosario, T; Luh, TY
      Fullerenes as a new class of radioprotectors

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    9. Maurici, D; Monti, P; Campomenosi, P; North, S; Frebourg, T; Fronza, G; Hainaut, P
      Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay

      ONCOGENE
    10. Yilmaz, A; Kaufmann, CC; Binder, C; Wormann, B; Haase, D
      Effects of amifostine in a patient with an advanced-stage myelodysplastic syndrome

      ANNALS OF HEMATOLOGY
    11. Rick, O; Beyer, J; Schwella, N; Schubart, H; Schleicher, J; Siegert, W
      Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor

      ANNALS OF ONCOLOGY
    12. Murley, JS; Kataoka, Y; Hallahan, DE; Roberts, JC; Grdina, DJ
      Activation of NF kappa B and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells

      FREE RADICAL BIOLOGY AND MEDICINE
    13. Spiegel, JH; Deschler, DG; Cheney, ML
      Microvascular transplantation and replantation of the rabbit submandibulargland

      ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    14. Perambakam, S; Li, BR; Preisler, H
      Quantitation of interferon regulatory factor transcripts in patients with acute myeloid leukemia

      CANCER INVESTIGATION
    15. Koukourakis, MI
      Clarification on the potential of subcutaneous ethyol as a radioprotectiveagent - Reply

      JOURNAL OF CLINICAL ONCOLOGY
    16. Tsiara, SN; Kapsali, HD; Panteli, K; Christou, L; Bourantas, KL
      Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    17. Buntzel, J; Bokemeyer, C; Wagner, W
      Recommendations of the Working Group 'Supportive Massnahmen in der Onkologie' concerning the clinical use of cytoprotectives

      ONKOLOGIE
    18. Jeong, YY; Mitchell, DG; Hann, HWL; Malin, AK; Kang, HK; Holland, GA; Capizzi, RL
      Hepatocellular carcinoma after systemic chemotherapy: Gadolinium-enhanced MR measurement of necrosis by volume histogram

      JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
    19. Antonadou, D; Coliarakis, N; Synodinou, M; Athanassiou, H; Kouveli, A; Verigos, C; Georgakopoulos, G; Panoussaki, K; Karageorgis, P; Throuvalas, N
      Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    20. Momm, F; Bechtold, C; Rudat, V; Strnad, V; Tsekos, A; Fischer, K; Henke, M
      Alteration of radiation-induced hematotoxicity by amifostine

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    21. Yavuz, AA; Aydin, F; Yavuz, MN; Ilis, E; Ozdemir, F
      Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine advanced pancreatic cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    22. Symon, Z; Levi, M; Ensminger, WD; Smith, DE; Lawrence, TS
      Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    23. Ghielmini, M; Van der Bosch, S; Bosshard, M; Pampallona, S; Gabutti, L; Egger, HP; Kiess, M; Cavalli, F; Sessa, C
      Phase I-II study of escalating doses of amifostine combined with high-dosecyclophosphamide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    24. Marmiroli, L
      Toxicity from combined modality therapy in head and neck cancer

      TUMORI
    25. Van den Brande, J; Panday, VRN; Hoekman, K; Rosing, H; Huijskes, RVHP; Verheijen, RHM; Beijnen, JH; Vermorken, JB
      Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    26. Landauer, MR; Castro, CA; Benson, KA; Hogan, JB; Weiss, JF
      Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327

      JOURNAL OF APPLIED TOXICOLOGY
    27. Koukourakis, MI; Yannakakis, D
      High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequel

      ANTICANCER RESEARCH
    28. Arboscello, E; Botta, M; Romero, D; Schenone, E; Mencoboni, M; Bogliolo, G; Pannacciulli, I
      Effects of retinoic acid and amifostine on in vitro growth of normal hemopoietic progenitor cells

      ANTICANCER RESEARCH
    29. Fiorentini, G; Giovanis, P; Leoni, M; De Giorgi, U; Cariello, A; Dazzi, C; Caldeo, A
      Amifostine (ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: Results of a phase I study

      HEPATO-GASTROENTEROLOGY
    30. Phan, TP; Crane, CH; Janjan, NA; Vrdoljak, E; Milas, L; Mason, KA
      WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment

      INTERNATIONAL JOURNAL OF PANCREATOLOGY
    31. Brenner, W; Kampen, WU; von Forstner, C; Brummer, C; Zuhayra, M; Muhle, C; Czech, N; Henze, E
      High-dose treatment with Re-186-HEDP or Sm-153-EDTMP combined with amifostine in a rabbit model

      JOURNAL OF NUCLEAR MEDICINE
    32. Galanopoulos, A; Kritikou-Griva, E; Gligori, J; Michalis, E; Grigoraki, V; Marinakis, T; Kakkas, J; Tasiopoulou, A; Anagnostopoulos, NI
      Treatment of patients with myelodysplastic syndrome with amifostine

      LEUKEMIA RESEARCH
    33. Tefferi, A; Elliott, MA; Steensma, DP; Hook, CC; Dispenzieria, A; Hanson, CA; Schroeder, G; Letendre, L
      Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome

      LEUKEMIA RESEARCH
    34. Fulda, S; Fichtner, I; Hero, B; Berthold, F
      Preclinical and clinical aspects on the use of amifostine as chemoprotectorin neuroblastoma patients

      MEDICAL AND PEDIATRIC ONCOLOGY
    35. Souid, AK; Fahey, RC; Aktas, MK; Sayin, OA; Karjoo, S; Newton, GL; Sadowitz, PD; Dubowy, RL; Bernstein, ML
      Blood thiols following amifostine and mesna infusions, a Pediatric Oncology Group study

      DRUG METABOLISM AND DISPOSITION
    36. Bhattacharya, R; Rao, PVL; Pant, SC; Kumar, P; Tulsawani, RK; Pathak, U; Kulkarni, A; Vijayaraghavan, R
      Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    37. Tran, NV; Chang, DW; Gupta, A; Kroll, SS; Robb, GL
      Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy

      PLASTIC AND RECONSTRUCTIVE SURGERY
    38. Shen, HX; Chen, ZJJ; Zilfou, JT; Hopper, E; Murphy, M; Tew, KD
      Binding of the aminothiol WR-1065 to transcription factors influences cellular response to anticancer drugs

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    39. Gradishar, WJ; Stephenson, P; Glover, DJ; Neuberg, DS; Moore, MR; Windschitl, HE; Piel, I; Abeloff, MD
      A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma - An Eastern Cooperative Oncology Group Study (E8188)

      CANCER
    40. von Schlippe, M; Fowler, CJ; Harland, SJ
      Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis

      BRITISH JOURNAL OF CANCER
    41. Hartmann, JT; von Vangerow, A; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

      BRITISH JOURNAL OF CANCER
    42. Johnson, PWM; Muers, MF; Peake, MD; Poulter, KM; Gurney, EM; Napp, V; Hepburn, PM; Brown, JM
      A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer

      BRITISH JOURNAL OF CANCER
    43. Ord, RA; Blanchaert, RH
      Current management of oral cancer - A multidisciplinary approach

      JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
    44. Mazur, L
      Radioprotective effects of the thiols GSH and WR-2721 against X-ray-induction of micronuclei in erythroblasts

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    45. Koukourakis, MI; Giatromanolaki, A; Kakolyris, S; Froudarakis, M; Georgoulias, V; Retalis, G; Bahlitzanakis, N
      Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer

      MEDICAL ONCOLOGY
    46. Fetscher, S; Mertelsmann, R
      Supportive care in hematologic malignancies: hematopoietic growth factors,infections, transfusion therapy

      CURRENT OPINION IN HEMATOLOGY
    47. Orditura, M; De Vita, F; Belli, A; Ciaramella, F; Musico, M; Ferrigno, A; Formato, R; Abbate, G; Diadema, MR; Catalano, G
      Efficacy and safety profile of amifostine in the preoperative combined therapy of esophageal cancer patients

      ONCOLOGY REPORTS
    48. Hartmann, JT; Knop, S; Fels, LM; van Vangerow, A; Stolte, H; Kanz, L; Bokemeyer, C
      The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors

      ANTI-CANCER DRUGS
    49. Ledney, GD; Elliott, TB; Harding, RA; Jackson, WE; Inal, CE; Landauer, MR
      WR-151327 increases resistance to Klebsiella pneumoniae infection in mixed-field- and gamma-photon-irradiated mice

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    50. North, S; El-Ghissassi, F; Pluquet, O; Verhaegh, G; Hainaut, P
      The cytoprotective aminothiol WR1065 activates p21(waf-1) and down regulates cell cycle progression through a p53-dependent pathway

      ONCOGENE
    51. Martens-Lobenhoffer, J; Fuhlroth, J; Ridwelski, K
      Influence of the administration of amifostine on the pharmacokinetics of 5-fluorouracil in patients with metastatic colorectal carcinoma

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    52. Hofmann, WK; Seipelt, G; Ottmann, OG; Kalina, U; Koschmieder, S; Brucher, J; Frickhofen, N; Klausmann, M; Mitrou, PS; Hoelzer, D
      Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels

      ANNALS OF HEMATOLOGY
    53. Capizzi, RL; Oster, W
      Chemoprotective and radioprotective effects of amifostine: An update of clinical trials

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    54. Herrstedt, J
      Prevention and management of mucositis in patients with cancer

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    55. Park, S; Merlat, A; Guesnu, M; Picard, F; Viguie, F; Vassilieff, D; Dreyfus, F
      Pure red cell aplasia associated with myelodysplastic syndromes

      LEUKEMIA
    56. Wijermans, P; Lubbert, M; Verhoef, G; Bosly, A; Ravoet, C; Andre, M; Ferrant, A
      Low-dose 5-aza-2 '-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients

      JOURNAL OF CLINICAL ONCOLOGY
    57. Miura, Y; Anzai, K; Ueda, J; Ozawa, T
      Novel approach to in vivo screening for radioprotective activity in whole mice: In vivo electron spin resonance study probing the redox reaction of nitroxyl

      JOURNAL OF RADIATION RESEARCH
    58. Porta, C; Maiolo, A; Tua, A; Grignani, G
      Amifostine, a reactive oxygen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF

      HAEMATOLOGICA
    59. Grossi, A; Fabbri, A; Santini, V; Leoni, F; Nozzoli, C; Longo, G; Pagliai, G; Ciolli, S; Ferrini, PR
      Amifostine in the treatment of low-risk myelodysplastic syndromes

      HAEMATOLOGICA
    60. Rudat, V; Meyer, J; Momm, F; Bendel, M; Henke, M; Strnad, V; Grotz, K; Schulte, A
      Protective effect of amifostine on dental health after radiotherapy of thehead and neck

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    61. Wasserman, T; Mackowiak, JI; Brizel, DM; Oster, W; Zhang, JL; Peeples, PJ; Sauer, R
      Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    62. Damron, TA; Spadaro, JA; Tamurian, RM; Damron, LA
      Sparing of radiation-induced damage to the physis: Fractionation alone compared to amifostine pretreatment

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    63. Bourhis, J; De Crevoisier, R; Abdulkarim, B; Deutsch, E; Lusinchi, A; Luboinski, B; Wibault, P; Eschwege, F
      A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    64. Herman, EH; Zhang, J; Chadwick, DP; Ferrans, VJ
      Comparison of the protective effects of amifostine and dexrazoxane againstthe toxicity of doxorubicin in spontaneously hypertensive rats

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    65. Marzatico, F; Porta, C; Moroni, M; Bertorelli, L; Borasio, E; Finotti, N; Pansarasa, O; Castagna, L
      In vitro antioxidant properties of amifostine (WR-2721, Ethyol)

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    66. Chauncey, TR; Gooley, TA; Lloid, ME; Schubert, MM; Lilleby, K; Holmberg, L; Bensinger, WI
      Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    67. Mazur, L; Czyzewska, A; Augustynek, A
      WR-2721: Inhibitor of cisplatin-induced micronuclei

      TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    68. Cronin, S; Uberti, JP; Ayash, LJ; Raith, C; Ratanatharathorn, V
      Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    69. Fauth, F; Martin, H; Sonnhoff, S; Bialleck, H; Wiesneth, M; Mihanovic, B; Hoelzer, D
      Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells

      BONE MARROW TRANSPLANTATION
    70. Renner, S; Krumpelmann, S; Bruchelt, G; Wiesinger, H; Niethammer, D; Klingebiel, T
      Effect of amifostine on neuroblastoma during high dose chemotherapy: In vivo and in vitro investigations

      ANTICANCER RESEARCH
    71. Czejka, M; Schueller, J; Eder, I; Reznicek, G; Kraule, C; Zeleni, U; Freitag, R
      Clinical pharmacokinetics and metabolism of paclitaxel after polychemotherapy with the cytoprotective agent amifostine

      ANTICANCER RESEARCH
    72. Illiano, A; Barletta, E; De Marino, V; Battiloro, C; Barzelloni, M; Scognamiglio, F; Rossi, N; Zampa, G; De Bellis, M; Gridelli, C
      New triplet chemotherapy combination with carboplatin, paclitaxel and gemcitabine plus amifostine support in advanced non small cell lung cancer: a phase II study

      ANTICANCER RESEARCH
    73. Dunst, J; Semlin, S; Pigorsch, S; Muller, AC; Reese, T
      Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients

      STRAHLENTHERAPIE UND ONKOLOGIE
    74. Gridelli, C; Guida, C; Barletta, E; Gatani, T; Fiore, F; Barzelloni, ML; Rossi, A; de Bellis, M; D'Aniello, R; Scognamiglio, F
      Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study

      LUNG CANCER
    75. Castiglione, F; Porcile, G; Gridelli, C
      The potential role of amifostine in the treatment of non small cell lung cancer

      LUNG CANCER
    76. Gridelli, C; Cigolari, S; Maiorino, A; Ianniello, GP; Brancaccio, L; Rossi, A; De Cataldis, G; Pedicini, T; Maiorino, L; Barletta, E; Di Lanno, M; Bilancia, D; Crispino, C; Barzelloni, ML; Masullo, P; D'Aniello, R; Manzione, L
      Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study

      LUNG CANCER
    77. Lindegaard, JC; Grau, C
      Has the outlook improved for amifostine as a clinical radioprotector?

      RADIOTHERAPY AND ONCOLOGY
    78. Hartmann, JT; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors

      INVESTIGATIONAL NEW DRUGS
    79. Li, BR; Yang, J; Tao, M; Nayini, J; Horvath, E; Chopra, H; Meyer, PM; Venugopal, P; Preisler, HD
      Poor prognosis acute myelogenous leukemia 2 - biological and molecular biological characteristics and treatment outcome

      LEUKEMIA RESEARCH
    80. Ribizzi, I; Darnowski, JW; Goulette, FA; Sertoli, MR; Calabresi, P
      Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line

      LEUKEMIA RESEARCH
    81. Danilatou, V; Lydaki, E; Dimitriou, H; Papazoglou, T; Kalmanti, M
      Bone marrow purging by photodynamic treatment in children with acute leukemia - Cytoprotective action of Amifostine

      LEUKEMIA RESEARCH
    82. Bowen, DT
      Oxidative stress and the myelodysplastic syndromes

      LEUKEMIA RESEARCH
    83. De Souza, CA; Santini, G; Marino, G; Nati, S; Congiu, AM; Vigorito, AC; Damasio, E
      Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    84. Shaw, PJ; Bleakley, M
      Systemic inflammatory response syndrome associated with amifostine

      MEDICAL AND PEDIATRIC ONCOLOGY
    85. Murray, D; Rosenberg, E; Allalunis-Turner, MJ
      Protection of human tumor cells of differing radiosensitivity by WR-1065

      RADIATION RESEARCH
    86. Damron, TA; Spadaro, JA; Margulies, B; Damron, LA
      Dose response of amifostine in protection of growth plate function from irradiation effects

      INTERNATIONAL JOURNAL OF CANCER
    87. Capelli, D; Santini, G; De Souza, C; Poloni, A; Marino, G; Montanari, M; Lucesole, M; Brunori, R; Massidda, D; Offidani, M; Leoni, P; Olivieri, A
      Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study

      BRITISH JOURNAL OF HAEMATOLOGY
    88. Kollmannsberger, C; Kuzcyk, M; Mayer, F; Hartmann, JT; Kanz, L; Bokemeyer, C
      Late toxicity following curative treatment of testicular cancer

      SEMINARS IN SURGICAL ONCOLOGY
    89. Bohuslavizki, KH; Klutmann, S; Jenicke, L; Kroger, S; Buchert, R; Mester, J; Clausen, M
      Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioicacid (amifostine) in high-dose radioiodine treatment: Results obtained in a rabbit animal model and in a double-blind multi-arm trial

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    90. Auletta, JJ; Shurin, S
      Improved hematopoiesis using amifostine in secondary myelodysplasia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    91. Gallardo, D; Mohar, A; Calderillo, G; Mota, A; Solorza, G; Lozano, A; Solano, P; De la Garza, J
      Cisplatin, radiation and amifostine in carcinoma of the uterine cervix

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    92. Orditura, M; De Vita, F; Roscigno, A; Infusino, S; Auriemma, A; Iodice, P; Ciaramella, F; Abbate, G; Catalano, G
      Amifostine: A selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review)

      ONCOLOGY REPORTS
    93. van Moorsel, CJA; Pinedo, HM; Veerman, G; Vermorken, JB; Postmus, PE; Peters, GJ
      Scheduling of gemcitabine and cisplatin in Lewis Lung tumour bearing mice

      EUROPEAN JOURNAL OF CANCER
    94. Martens, ACM; Hagenbeek, A
      Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia

      EUROPEAN JOURNAL OF CANCER
    95. Planting, AST; Catimel, G; de Mulder, PHM; de Graeff, A; Hoppener, F; Verweij, J; Oster, W; Vermorken, JB
      Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer

      ANNALS OF ONCOLOGY
    96. Tamurian, RM; Damron, TA; Spadaro, JA
      Sparing radiation-induced damage to the physis by radioprotectant drugs: Laboratory analysis in a rat model

      JOURNAL OF ORTHOPAEDIC RESEARCH
    97. Buntzel, J
      Experiences with selenium in the treatment of acute and late toxicities due to radiochemotherapy of head and neck cancer

      MEDIZINISCHE KLINIK
    98. Santini, V; Giles, FJ
      The potential of amifostine: from cytoprotectant to therapeutic agent

      HAEMATOLOGICA
    99. Mazur, L; Blawat, A
      Effects of GSH and WR-2721 on induction of micronuclei by cyclophosphamide

      TOXICOLOGY LETTERS
    100. Bohuslavizki, KH; Klutmann, S; Jenicke, L; Brenner, W; Feyerabend, B; Henze, E; Clausen, M
      Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 06:20:26